全文获取类型
收费全文 | 1715篇 |
免费 | 102篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 75篇 |
妇产科学 | 41篇 |
基础医学 | 220篇 |
口腔科学 | 124篇 |
临床医学 | 104篇 |
内科学 | 412篇 |
皮肤病学 | 66篇 |
神经病学 | 137篇 |
特种医学 | 51篇 |
外科学 | 190篇 |
综合类 | 11篇 |
预防医学 | 137篇 |
眼科学 | 89篇 |
药学 | 64篇 |
中国医学 | 2篇 |
肿瘤学 | 76篇 |
出版年
2023年 | 10篇 |
2022年 | 26篇 |
2021年 | 37篇 |
2020年 | 37篇 |
2019年 | 56篇 |
2018年 | 47篇 |
2017年 | 39篇 |
2016年 | 26篇 |
2015年 | 52篇 |
2014年 | 63篇 |
2013年 | 61篇 |
2012年 | 98篇 |
2011年 | 99篇 |
2010年 | 43篇 |
2009年 | 43篇 |
2008年 | 88篇 |
2007年 | 114篇 |
2006年 | 79篇 |
2005年 | 74篇 |
2004年 | 59篇 |
2003年 | 56篇 |
2002年 | 51篇 |
2001年 | 39篇 |
2000年 | 55篇 |
1999年 | 46篇 |
1998年 | 28篇 |
1997年 | 16篇 |
1996年 | 12篇 |
1995年 | 14篇 |
1994年 | 23篇 |
1993年 | 30篇 |
1992年 | 60篇 |
1991年 | 40篇 |
1990年 | 39篇 |
1989年 | 29篇 |
1988年 | 23篇 |
1987年 | 13篇 |
1986年 | 10篇 |
1985年 | 13篇 |
1984年 | 14篇 |
1983年 | 12篇 |
1982年 | 7篇 |
1979年 | 3篇 |
1978年 | 5篇 |
1974年 | 6篇 |
1970年 | 3篇 |
1969年 | 3篇 |
1967年 | 3篇 |
1966年 | 4篇 |
1965年 | 3篇 |
排序方式: 共有1822条查询结果,搜索用时 15 毫秒
1.
2.
Thomas Donohue Morton J. Kern Richard Bach Frank Aguirre Thomas Wolford 《Catheterization and cardiovascular interventions》1993,28(2):155-161
The vasomotor response of native human collateral vessels to pharmacologic or hemodynamic vasodilatory stimuli is not well known. We describe a case where retrograde collateral flow velocity was measured both at baseline and following selected hemodynamic and pharmacologic interventions. This index case represents the first in a series of potential human physiologic studies designed to address questions pertaining to control of collateral blood supply in humans. © 1993 Wiley-Liss, Inc. 相似文献
3.
A Aguirre Vila-Coro S Bonafonte J N Fernandez del Cotero 《Annals of ophthalmology》1988,20(10):367-370
Two patients underwent bilateral radial keratotomy procedures and developed epithelial inclusion cysts as a postoperative complication. Metal blades were used for the corneal incisions; this might be related to the development of the cysts. 相似文献
4.
Juan Carlos Gómez-Esteban Juan Jose Zarranz Elena Lezcano Fernando Velasco Roberto Ciordia Idoia Rouco Jose Losada Iker Bilbao 《Movement disorders》2006,21(7):983-988
The aim of this research was to quantify sleep problems in patients suffering from Parkinson's disease by means of the new Parkinson's Disease Sleep Scale (PDSS) and to correlate such problems with the possible influence of current drug treatment. A total of 70 patients (36 men and 34 women) with a diagnosis of Parkinson's disease were enrolled. Their mean age was 69.7 +/- 8.2 years, and duration of disease was 7.4 +/- 4.8 years. All patients completed the PDSS and the Unified Parkinson's Disease Rating Scale (UPDRS Parts I-IV). Drug consumption and doses were registered. The mean score on the PDSS scale was 109.23 +/- 19.75 and on the UPDRS III scale was 25.24 +/- 11.35. The lowest scores were obtained in Item 3 (sleep fragmentation): 5.53 (2.46); and in Item 8 (nocturia): 5.75 (2.91). There was a weak correlation between the PDSS and UPDRS III (cc = -0.355, P = 0.003), PDSS and UPDRS I (cc = -0.272, P = 0.02), and PDSS and UPDRS IV (cc = -0.416, P < 0.001). Motor conditions, mental state, and drug complications influence sleep quality. Although this effect was significant, it was not of a great magnitude. Dopaminergic drugs did not increase daytime sleepiness. As a whole, sleep quality in patients who took dopaminergic agonists did not differ from that of patients who took levodopa in monotherapy. 相似文献
5.
We reviewed clinical, EEG, and CT findings of 203 patients with epilepsy due to neurocysticercosis. Seizures were generalized in 121 patients and partial in 82. Thirty-two patients had focal signs and eight had papilledema. Eighty-one had generalized and 16 had focal EEG abnormalities. CT showed parenchymal brain calcifications in 53 patients and cysts in 150. There was an increased rate of focal signs in patients with single cysts as compared with patients with multiple cysts, and focal EEG abnormalities were present only in patients with single cysts. Fifty patients were lost to follow-up. The remaining 153 patients were followed for 28 +/- 6 months; of these, 31 had calcifications and 122 had cysts. Anticonvulsants were started after the first visit in every patient. The 31 patients with calcifications remained free of seizures. Ninety-five of the 122 patients with cysts were also treated with anticysticercal drugs; of these, 79 (83%) had control of seizures. In contrast, only seven (26%) of 27 patients who did not receive anticysticercal drugs had control of seizures, indicating a strong correlation between the use of anticysticercal drugs and seizure control. Finally, of the 21 patients in whom anticonvulsants were withdrawn, 16 had relapses. 相似文献
6.
7.
O H Del Brutto J Sotelo R Aguirre E Díaz-Calderón T A Alarcón 《Archives of neurology》1992,49(5):535-538
Albendazole is considered to be the drug of choice for treatment of parenchymal brain cysticercosis. Its efficacy, however, for treatment of subarachnoid cysticerci has not been established, to our knowledge. In this study, we treated four patients who had giant subarachnoid cysticerci with albendazole at daily doses of 15 mg/kg of body weight for 8 days. Computed tomographic studies showed that all cysts disappeared 3 months after the end of treatment. This was associated with marked clinical improvement in every case. Our results indicated that albendazole is highly effective for treatment of this form of the disease. 相似文献
8.
9.
José M Quintana Inmaculada Arostegui Antonio Escobar Iratxe Lafuente Juan C Arenaza Isidoro Garcia Urko Aguirre 《BMC musculoskeletal disorders》2007,8(1):84
Background
To develop a sensitive and specific screening tool for knee and hip osteoarthritis in the general population of elderly people. 相似文献10.
R Martínez Jordá C Aguirre R Calvo J M Rodríguez-Sasiaín S Erill 《The Journal of pharmacy and pharmacology》1990,42(3):164-166
Penbutolol is a beta-adrenoceptor antagonist that is extensively bound to alpha 1-acid glycoprotein (alpha 1-AGP), a protein that increases in inflammatory diseases thereby binding more drug in such conditions. Changes in serum binding can lead to modifications in the pharmacokinetics and pharmacodynamics of a drug, therefore, the central effect (as the anticonvulsant response) and brain uptake of penbutolol given intravenously to mice with experimental inflammation have been measured. A significant decrease of the central effect of penbutolol and its brain uptake was seen in diseased when compared with control animals (P less than 0.01). A parallel decrease in free fraction of penbutolol in diseased vs normal animals was detected. These results suggest that there is an increase in serum binding of basic drugs related to increments in alpha 1-AGP concentration, which reduces their central pharmacological effect. 相似文献